Exact Sciences Corporation (EXAS) Institutional Ownership
Track institutional investors, ownership changes, and 13F filings.
Ownership Summary
Total Institutions
620
Total Shares Held
183.93M
Total Value
$10.27B
Institutional Holding %
99.53%
Ownership Distribution
Top 5 Holders
Top Institutional Holders (as of Dec 31, 2024)
| Institution | Shares | Ownership % | Value |
|---|---|---|---|
| FMR | 20.75M | 11.23% | $1.17B |
| CAPITAL WORLD INVESTORS | 17.54M | 9.49% | $985.44M |
| VANGUARD | 17.02M | 9.21% | $956.37M |
| WELLINGTON LLP | 12.06M | 6.53% | $677.57M |
| BlackRock | 11.87M | 6.42% | $666.97M |
| STATE STREET | 6.23M | 3.37% | $350.22M |
| PRICE T ROWE | 5.76M | 3.12% | $323.67M |
| T. ROWE PRICE | 4.27M | 2.31% | $239.92M |
| AMERIPRISE FINANCIAL | 4.21M | 2.28% | $236.45M |
| JPMorgan CHASE | 3.49M | 1.89% | $196.30M |
Recent Insider Trading
| Insider | Title | Transaction | Shares | Value | Date |
|---|---|---|---|---|---|
| Conroy Kevin T | Director, President And Ceo | M-Exempt | 66.72K | $1.49M | Mar 07, 2025 |
| Conroy Kevin T | Director, President And Ceo | F-InKind | 48.93K | $2.30M | Mar 07, 2025 |
| Conroy Kevin T | Director, President And Ceo | M-Exempt | 66.72K | $1.49M | Mar 07, 2025 |
| Herriott James | Svp, General Counsel & Sec | M-Exempt | 2.38K | $- | Feb 28, 2025 |
| Herriott James | Svp, General Counsel & Sec | F-InKind | 1.12K | $53.41K | Feb 28, 2025 |
| Herriott James | Svp, General Counsel & Sec | M-Exempt | 1.89K | $- | Feb 28, 2025 |
| Herriott James | Svp, General Counsel & Sec | F-InKind | 889 | $42.51K | Feb 28, 2025 |
| Herriott James | Svp, General Counsel & Sec | M-Exempt | 2.38K | $- | Feb 28, 2025 |
| Herriott James | Svp, General Counsel & Sec | M-Exempt | 1.89K | $- | Feb 28, 2025 |
| Conroy Kevin T | Director, President And Ceo | M-Exempt | 22.17K | $- | Feb 28, 2025 |
Recent Position Changes
| Institution | Shares Changed | % Change | Date |
|---|---|---|---|
| PRICE T ROWE | +2.46M | +74.65% | Feb 14, 2025 |
| WELLINGTON LLP | -2.27M | -15.86% | Feb 12, 2025 |
| ARTISANHIP | -1.81M | -47.32% | Feb 12, 2025 |
| JPMorgan CHASE | -1.76M | -33.54% | Feb 12, 2025 |
| CAPITAL WORLD INVESTORS | +1.70M | +10.71% | Feb 13, 2025 |
| ARMISTICE | +1.62M | +100.00% | Feb 14, 2025 |
| MACKENZIE FINANCIAL | +1.51M | +107.71% | Feb 20, 2025 |
| UBS | +1.18M | +383.08% | Feb 14, 2025 |
| MILLENNIUM | +1.12M | +90.53% | Feb 14, 2025 |
| HOLOCENE | -971.89K | -51.99% | Feb 14, 2025 |
Recent Ownership Filings
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 10, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 04, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 04, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 04, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 04, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 04, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 26, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 26, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 26, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 26, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 26, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 26, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 21, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 21, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 21, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 21, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 21, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 21, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Jan 06, 2025
Related Metrics
Explore detailed financial metrics and analysis for EXAS.